FDA

Grail liquid biopsy
MedTech

Grail survives adcomm vote as it awaits FDA decision

Grail has beaten the odds and seen a positive recommendation for its multi-cancer blood test Galleri from FDA advisors.
Ben Adams Sep 24, 2026 9:10am
Brain

FDA approves Pixclara, the first FET-PET drug for brain cancer

Sep 15, 2026 7:40am
FDA
Favicon Fierce Pharma

New FDA oncology chief sets priorities in first interview

Sep 11, 2026 4:00am
pause button on blue background

Biohaven epilepsy drug suffers FDA hold days after $350M deal

Sep 10, 2026 10:03am
AZ
Favicon Fierce Pharma

FDA's surprise approval of AZ's oral SERD sets new paradigm

Sep 8, 2026 10:35am
Spine

FDA says Boston Scientific recalls spinal cord implant

Sep 8, 2026 8:14am